| Insulin-like Growth Factor-binding Protein-7 (IGFBP7): A Promising Gene Therapeutic for Hepatocellular Carcinoma (HCC). | |
| | |
MedLine Citation:
|
PMID: 23319057 Owner: NLM Status: Publisher |
Abstract/OtherAbstract:
|
Hepatocellular carcinoma (HCC) is a highly fatal disease mandating development of novel, targeted therapies to elicit prolonged survival benefit to the patients. Insulin-like growth factor-binding protein-7 (IGFBP7), a secreted protein belonging to the IGFBP family, functions as a potential tumor suppressor for HCC. In the present study, we evaluated the therapeutic efficacy of a replication-incompetent adenovirus expressing IGFBP7 (Ad.IGFBP7) in human HCC. Ad.IGFBP7 profoundly inhibited viability and induced apoptosis in multiple human HCC cell lines by inducing reactive oxygen species (ROS) and activating a DNA damage response (DDR) and p38 MAPK. In orthotopic xenograft models of human HCC in athymic nude mice, intravenous administration of Ad.IGFBP7 profoundly inhibited primary tumor growth and intrahepatic metastasis. In a nude mice subcutaneous model, xenografts from human HCC cells were established in both flanks and only left-sided tumors received intratumoral injection of Ad.IGFBP7. Growth of both left-sided injected tumors and right-sided uninjected tumors were markedly inhibited by Ad.IGFBP7 with profound suppression of angiogenesis. These findings indicate that Ad.IGFBP7 might be a potent therapeutic eradicating both primary HCC and distant metastasis and might be an effective treatment option for terminal HCC patients.Molecular Therapy (2013); doi:10.1038/mt.2012.282. |
| | |
Authors:
|
Dong Chen; Ayesha Siddiq; Luni Emdad; Devaraja Rajasekaran; Rachel Gredler; Xue-Ning Shen; Prasanna K Santhekadur; Jyoti Srivastava; Chadia L Robertson; Igor Dmitriev; Elena A Kashentseva; David T Curiel; Paul B Fisher; Devanand Sarkar |
Related Documents
:
|
18729497 - Membrane glycoproteins associated with breast tumor cell progression identified by a le... 23386687 - Equivalent benefit of rapamycin and a potent mtor atp-competitive inhibitor, mln0128 (i... 23349677 - Biological stoichiometry in tumor micro-environments. 14747837 - Pharmacological modulation of local feedback mechanisms as a therapeutic approach in br... 1988117 - Lonidamine as a modulator of alkylating agent activity in vitro and in vivo. 6092297 - Assessment and treatment of neurogenic and non-neurogenic tumors of the parapharyngeal ... |
Publication Detail:
|
Type: JOURNAL ARTICLE Date: 2013-1-15 |
Journal Detail:
|
Title: Molecular therapy : the journal of the American Society of Gene Therapy Volume: - ISSN: 1525-0024 ISO Abbreviation: Mol. Ther. Publication Date: 2013 Jan |
Date Detail:
|
Created Date: 2013-1-15 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 100890581 Medline TA: Mol Ther Country: - |
Other Details:
|
Languages: ENG Pagination: - Citation Subset: - |
Affiliation:
|
Department of Pathology, Virginia Commonwealth University, School of Medicine, Richmond, Virginia, USA. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Microdystrophin Ameliorates Muscular Dystrophy in the Canine Model of Duchenne Muscular Dystrophy.
Next Document: Differential Type I Interferon-dependent Transgene Silencing of Helper-dependent Adenoviral vs. Aden...